Creative Biolabs-Immuno-oncology

Anti-DYNLT3 (clone 1G0ZA3-CA-8P1G) SynExpress pU-Cy2-I17-B Modified CD8+ T cells (CAT#: ITS-1224-CR2432)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target DYNLT3 (clone 1G0ZA3-CA-8P1G). We employs the Retrovirus (pUC-Cy2-IL-17-BamHI) vector components and the SynExpress system of the Exons Inversion/Negative feedback for a robust and sustained response against cancers.
Host
Mouse
Target
DYNLT3
Clone
1G0ZA3-CA-8P1G
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy2
Promoter
pUC
Effector Gene
IL-17
Insertion Sites
BamHI
Gene Modification
Inversion
Modification Domain
Exons
Carrier Type
Retrovirus
Transformation Accuracy
0.87
Cell Culture
Adherent Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving